What are the potential complications of stem cell therapy from umbilical cord (UC) blood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Complications of Umbilical Cord Blood Stem Cell Therapy

The most critical complication of umbilical cord blood stem cell therapy is thrombotic events, including venous thrombosis and potentially fatal pulmonary embolism, which has been documented with intravenous infusion of umbilical cord-derived mesenchymal stem cells. 1

Thrombotic Complications

Venous Thromboembolism

  • Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have caused venous thrombosis in the forearm at sites distant from injection, confirmed by Doppler ultrasound imaging, with elevated D-dimer levels documented on baseline coagulation tests. 1
  • Treatment required warfarin and urokinase as thrombolytic therapy for clot reduction. 1
  • These thrombotic events occur due to instant blood-mediated inflammatory reaction (IBMIR) triggered by tissue factor (TF) expression on placental tissue-derived stem cells. 1

Mechanism of Thrombosis

  • Placental tissue-derived stem cells, including UC-MSCs, trigger stronger IBMIR responses compared to bone marrow-derived cells when tested without additives. 1
  • The procoagulant activity is modulated by multiple parameters including donor tissue type and ex vivo processing methods. 1
  • High doses of placental tissue-derived products show increased rates of infusion reactions. 1

Infusion-Related Complications

Dose-Dependent Toxicity

  • An increased rate of infusion reactions has been reported specifically for high doses of placental tissue-derived products, including umbilical cord blood stem cells. 1
  • The severity of IBMIR is influenced by the dose administered, with higher doses triggering more severe responses. 1

Processing-Related Factors

  • Freeze-thawed mesenchymal stem cells trigger stronger IBMIR when washed with buffer containing human blood type AB plasma instead of human serum. 1
  • A mild increase in adverse events was reported for infusion of large doses of cryopreserved MSCs compared to fresh cells. 1
  • Culture expansion, culture media, and cell suspension buffer all impact the degree of IBMIR triggering. 1

Transplantation-Specific Complications

Graft-Versus-Host Disease (GVHD)

  • While umbilical cord blood carries diminished risk of GVHD compared to similarly mismatched peripheral blood or bone marrow stem cells, it remains a potential complication. 1
  • The "naive" nature of cord blood lymphocytes explains the lower incidence and severity of GVHD compared to allogeneic bone marrow transplant settings. 2

Engraftment Challenges

  • The limited number of hematopoietic stem cells that can be harvested from umbilical cord results in slower time to engraftment and higher transplant-related mortality, mainly due to prolonged aplasia periods. 2
  • Prolonged aplasia increases susceptibility to viral and fungal infections during the post-transplant period. 2
  • Total nucleated cell count requirements of >2.5-4.0 × 10^7/kg must be met to minimize engraftment complications. 3

Infectious Complications

  • The prolonged period of bone marrow aplasia leads to severe, prolonged neutropenia and thrombocytopenia. 4
  • Patients face increased susceptibility to viral and fungal infections during the extended aplasia period after transplantation. 2

Autologous Use Concerns

Malignancy-Related Risks

  • There is no evidence of safety or effectiveness of autologous cord blood stem cell transplantation for treatment of malignant neoplasms. 1
  • Evidence demonstrates the presence of DNA mutations in cord blood obtained from children who subsequently develop leukemia, making autologous cord blood transplantation potentially contraindicated in children who develop leukemia. 1

Limited Clinical Evidence

  • No accurate estimates exist of the likelihood of children needing their own stored cord blood stem cells in the future, with estimates ranging from 1 in 1,000 to more than 1 in 200,000. 1

Risk Mitigation Strategies

Anticoagulation Considerations

  • Many acutely ill patients in trials reporting safety of MSCs were already receiving anticoagulation treatment (anti-platelet drugs, low molecular weight heparin, dextran sulfate). 1
  • Research findings may not be generalizable to systemically activated/proinflammatory patients who do not receive anticoagulation treatment at the time of cell infusion. 1

Optimized Delivery Procedures

  • The clinical need for increased caution and optimized delivery procedures with placental tissue-derived MSCs, including UC-MSCs, is critical to prevent thrombotic complications. 1
  • Low doses of placental-derived stem cells trigger only weak IBMIR responses when optimized reconstitution and application protocols are followed. 1

Common Pitfalls to Avoid

  • Never administer high doses of umbilical cord-derived mesenchymal stem cells without anticoagulation prophylaxis in high-risk patients. 1
  • Do not assume that all cord blood stem cell products have equivalent safety profiles—placental tissue-derived cells carry higher thrombotic risk than bone marrow-derived cells. 1
  • Avoid using autologous cord blood for malignancies without considering the risk of pre-existing genetic mutations. 1
  • Do not underestimate the prolonged engraftment time and infection risk associated with cord blood transplantation, particularly in adult patients. 2

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Research

[Umbilical cord blood as a source of stem cells].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006

3
Guideline

Cord Blood Typing and Transplantation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the role of cord blood (umbilical cord blood) in stem cell transplantation for patients with hematological disorders, such as leukemia or lymphoma?
What is the recommended approach for using oral corticosteroids (e.g. prednisone) in a patient with Hidradenitis Suppurativa (HS)?
For an elderly, obese, bedridden female patient with a history of type 2 diabetes mellitus (T2DM) and recent development of bed sores, presenting with bilateral leg swelling for six months without signs of inflammation or hypertension, would it be wise to initiate treatment with furosemide (10 mg) and serrotiopeptidase (25 mg) to reduce the swelling?
What are the potential interactions and risks of combining tolperisone, dimenhydrinate, cinnarizine, and hydroxychloroquine (Plaquenil) in an adult patient with a history of muscle spasms, vertigo, and a possible autoimmune condition?
What is the recommended dosing for Depakote (valproate) in a patient requiring mood stabilization, considering factors such as age, medical history, renal function, and liver function?
What is the standard dosing of betahistine (Histamine receptor agonist) for a patient with Benign Paroxysmal Positional Vertigo (BPPV)?
Can a kidney transplant be performed in a patient with Hepatitis B (HBV) infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question